Detail
LncRNA Name | MIR222HG |
Synonyms | Lnc-Ang362 |
Region | GRCh38_X:45745211-45770274 Sequence |
Ensembl | ENSG00000270069 |
RefSeq | NA |
Circulating | ✘ |
Drug-resisitant | ✘ |
Prognostic | ✘ |
MiRNA | ✔ |
Variant | ✘ |
TF | ✘ |
Methylation | ✘ |
Cancer Name | prostate cancer |
ICD-0-3 | C61.9 |
Methods | qPCR, luciferase reporter assay, RIP, in vitro knockdown etc. |
Sample | cell line (LNCaP, LNCaP-Abl), PCa tumor tissues |
Expression Pattern | up-regulated |
Function Description | Upon promoter activation, a set of polyadenylated long non-coding RNA (lncRNA) MIR222HGs was transcribed from this promoter region. Over-expression of these MIR222HGs increased androgen-independent cell growth and repressed the expression of androgen receptor-regulated dihydrotestosterone (DHT)-induced KLK3, TMPRSS2, and FKBP5 in HSPC LNCaP cells, hallmarks of the CRPC phenotype. Clinically, increased expression of MIR222HG is associated with PCa progression to CRPC.MIR222HG may potentially affect miR-mediated expression silencing, subsequently leading to AR reprogramming. Our study highlights an essential role of a non-coding RNA in CRPC development and that differential activation of a single promoter can up-regulate two different types of non-coding RNAs, miR-221/222 and lncRNA MIR222HG, in CRPC. |
Pubmed ID | 29540675 |
Year | 2018 |
Title | Expression of lncRNA MIR222HG co tra Source Oncogenesis SO 2018 Mar 13 7 3 30[PMIDT29540675] |
External Links |
Links for MIR222HG | GenBank HGNC lncrnadb Noncode |
Links for prostate cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.